|
Qiagen N.V. - Comparative Business Analysis Snapshot
Business Description
Qiagen N.V.. The Group's principal activities are the production and distribution of technologies for the separation, purification and handling of DNA, RNA and proteins. The Group also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. The Group's products are used in biological research, research institutions, forensics, diagnostic and therapeutic industries. Brand names include QIAexpress, QIAwell, QIAEX and QIAprep. The Group operates worldwide. It acquired Corbett Life Science Pty. Ltd. in 2008.
Competitor Analysis
This analysis compares Qiagen N.V. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
